Scarica l'app Stockscreener
18.66
0.54%
0.10
Dopo l'orario di chiusura:
18.66
Precedente Chiudi:
$18.56
Aprire:
$18.4
Volume 24 ore:
242.91K
Relative Volume:
0.68
Capitalizzazione di mercato:
$513.44M
Reddito:
$320.35M
Utile/perdita netta:
$-75.01M
Rapporto P/E:
-7.7903
EPS:
-2.3953
Flusso di cassa netto:
$-113.17M
1 W Prestazione:
-2.10%
1M Prestazione:
-7.44%
6M Prestazione:
-20.93%
1 anno Prestazione:
-12.23%
Intervallo 1D:
$18.28
$18.82
Intervallo di 1 settimana:
$18.28
$19.28
Portata 52W:
$13.46
$31.04
Fulgent Genetics Inc Stock (FLGT) Company Profile
Nome
Fulgent Genetics Inc
Settore
Industria
Telefono
626-350-0537
Indirizzo
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, NTRA, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
18.66 | 510.68M | 320.35M | -75.01M | -113.17M | -2.3953 |
TMO
Thermo Fisher Scientific Inc
|
585.51 | 217.52B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.63 | 142.32B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
314.18 | 44.67B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
546.09 | 43.41B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.45 | 41.95B | 7.23B | 1.41B | 1.09B | 4.979 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-05 | Aggiornamento | UBS | Neutral → Buy |
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2022-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-02-04 | Ripresa | Piper Sandler | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-01-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-08-20 | Iniziato | Oppenheimer | Outperform |
| 2020-05-29 | Iniziato | BTIG Research | Buy |
| 2019-11-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - AOL.com
Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP - MarketBeat
Fulgent Genetics (FLGT) Short Interest & Short Float | Updated Aug 2026 $FLGT - MarketBeat
Discipline and Rules-Based Execution in FLGT Response - Stock Traders Daily
Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell - MarketBeat
Fulgent Genetics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking Alpha
Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0 - TradingView
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a Complicated Financial Landscape in Healthcare - DirectorsTalk Interviews
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets - Yahoo Finance
Fulgent Deadline Alert - TMX Newsfile
FLGT Maintained by Piper Sandler -- Price Target Raised to $19.0 - GuruFocus
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Fulgent Genetics Inc (7F0) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Fulgent Genetics, Inc. (NASDAQ:FLGT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results - MarketBeat
Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ... By GuruFocus - Investing.com Canada
Earnings call transcript: Fulgent Genetics cuts 2026 outlook after q2 miss - Investing.com Nigeria
FLGT Looks 16.7% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
Fulgent Reports Second Quarter 2026 Financial Results - businesswire.com
Fulgent Genetics Latest Results: Cuts FY26 EPS Guidance to Loss - scanx.trade
Behavioral Patterns of FLGT and Institutional Flows - Stock Traders Daily
Fulgent Genetics Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Fulgent Genetics Inc (FLGT) Cash Flow - TradingKey
Fulgent Genetics Inc (FLGT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Fulgent Genetics Inc (FLGT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Fulgent Genetics Inc (FLGT) Institutional Confidence - TradingKey
FLGT|Fulgent Genetics Inc|Price:19.670|Chg%:-0.310 - TradingKey
Fulgent Genetics Slips 1.5% as Shares Test Key Support LevelsALMA Signal - dars.gov.et
TradingKey - TradingKey
FLGT|Fulgent Genetics Inc|Price:19.557|Chg%:-0.113 - TradingKey
Fulgent Genetics, Inc. Revenue Breakdown – FWB:7F0 - TradingView
FULGENT GENETICS, INC. (FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (FLGT) - TMX Newsfile
Fulgent Genetics (FLGT.US) will release its earnings report after market close on July 30. - 富途牛牛
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating Challenges with a -7.41% Potential Downside - DirectorsTalk Interviews
Fulgent Genetics Inc (FLGT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Fulgent Genetics (FLGT) to Release Earnings on Thursday - MarketBeat
(FLGT) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
ETFs Investing in Fulgent Genetics, Inc. Stocks - TradingView
Fulgent Genetics seen as undervalued with stron... - Pluang
Fulgent Genetics: Strong Moves By Management Keep Me Bullish (NASDAQ:FLGT) - Seeking Alpha
Y Intercept Hong Kong Ltd Invests $1.08 Million in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics Inc. (FLGT) Q1 2026 Earnings: EPS Misses Estimates as Losses Widen, Shares Edge Lower - dars.gov.et
Fulgent to Announce Second Quarter 2026 Financial Results on Thursday, July 30, 2026 - Business Wire
Fulgent Genetics to announce Q2 2026 results on July 30 - scanx.trade
Fulgent Announces Rapid Oral Full Abstract Publication for FID-007 Within the Head and Neck Cancer Track Session at the ASCO 2026 Annual Meeting - AOL.com
FLGTFulgent Genetics Inc Forecast, Target Price - Finviz
Enterprise value to EBITDA forward of Fulgent Genetics, Inc. – NASDAQ:FLGT - TradingView
Fulgent Genetics (FLGT) Dips 1%: Testing Key Support Near $19.3 Amid Mixed Technical SignalsVOLD Alert - dars.gov.et
Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Fulgent Genetics Inc Azioni (FLGT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Gao Hanlin | Chief Scientific Officer |
Jun 02 '26 |
Sale |
17.89 |
1,688 |
30,191 |
990,374 |
1.64%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):